Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin
- PMID: 8990061
- DOI: 10.1002/mds.870120117
Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin
Abstract
Seventy-six consecutive patients with cervical dystonia. (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed significant improvement. Tsui and TWSTRS score reduction rates correlated significantly with each other, and each correlated with the global scale. Analysis of these scales and TWSTRS subscales indicates that an objective scale of severity such as either the Tsui rating scale or TWSTRS severity subscale used in conjunction with the TWSTRS pain subscale adequately assesses improvement of CD following treatment with botulinum toxin.
Similar articles
-
Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.J Neural Transm (Vienna). 2013 Mar;120(3):487-96. doi: 10.1007/s00702-012-0887-7. Epub 2012 Aug 17. J Neural Transm (Vienna). 2013. PMID: 22899277 Free PMC article. Review.
-
[Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].Brain Nerve. 2009 Jan;61(1):65-71. Brain Nerve. 2009. PMID: 19177808 Japanese.
-
BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).Mov Disord. 1997 Sep;12(5):772-5. doi: 10.1002/mds.870120526. Mov Disord. 1997. PMID: 9380065
-
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.Parkinsonism Relat Disord. 2010 Jun;16(5):316-23. doi: 10.1016/j.parkreldis.2010.03.002. Epub 2010 Mar 31. Parkinsonism Relat Disord. 2010. PMID: 20359934 Clinical Trial.
-
Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.Drugs. 2002;62(4):705-22. doi: 10.2165/00003495-200262040-00011. Drugs. 2002. PMID: 11893235 Review.
Cited by
-
Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.Mov Disord Clin Pract. 2015 Jun;2(2):135-141. doi: 10.1002/mdc3.12131. Epub 2015 Apr 6. Mov Disord Clin Pract. 2015. PMID: 27088112 Free PMC article.
-
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia.J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):6-12. doi: 10.1136/jnnp.64.1.6. J Neurol Neurosurg Psychiatry. 1998. PMID: 9436720 Free PMC article. Clinical Trial.
-
Comparison between (18)F-FDG PET/CT and EMG Mapping for Identifying Dystonic Superficial Muscles in Primary Cervical Dystonia: Preliminary Results.Nucl Med Mol Imaging. 2010 Apr;44(1):33-8. doi: 10.1007/s13139-009-0004-5. Epub 2010 Feb 26. Nucl Med Mol Imaging. 2010. PMID: 24899935 Free PMC article.
-
Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms.EJNMMI Res. 2017 Oct 25;7(1):87. doi: 10.1186/s13550-017-0338-4. EJNMMI Res. 2017. PMID: 29071431 Free PMC article.
-
Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.J Neural Transm (Vienna). 2013 Mar;120(3):487-96. doi: 10.1007/s00702-012-0887-7. Epub 2012 Aug 17. J Neural Transm (Vienna). 2013. PMID: 22899277 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical